(2 years, 11 months ago)
Commons ChamberFrom the moment they learned about omicron, the vaccine manufacturers, particularly those that make the so-called mRNA-type vaccines, started work on new omicron-targeting vaccines. It is hard to put a timing on this, not least because the companies themselves are unable to, but it is reasonable to think that they can move very quickly. Some of the conversations I have had suggest that they may well be able to have vaccines ready for trial within weeks. There would obviously have to be a trial to ensure that they were safe and effective, but there may be cases where they could be used in emergency situations. On the question about the two doses and a booster, we do not have reliable data on that at this point. However, the information I referred to in my statement on the impact of vaccinations showed that South Africans, in this case, who had had two doses of the vaccine and who had also had an infection had a higher level of protection than those who had not had an infection. This suggests that that hybrid outcome, where someone has had an infection and two doses, is not too dissimilar from having a booster shot and that it had a positive outcome.
It’s déjà vu all over again, isn’t it? I remind the Secretary of State that in March 2020 we were asked to impose restrictions for three weeks while the health service capacity was increased. Can he tell the House how much that capacity has now been increased? Secondly, in moving from a world that last week depended on isolation to one that this week depends on testing, is he saying that the statutory instrument that was approved in this House on Tuesday last week will be rescinded, today or tomorrow?
On NHS capacity, since March 2020 there has been a significant increase in ICU capacity. My hon. Friend will know that most beds in hospitals are still for people who need emergency care. There are still approximately 6,000 beds in England taken up by covid patients with the delta variant, and around 4,000 beds that are not available for use because of infection control procedures that are still in place. On the timing of the regulations, I have said that there will be a review on 5 January and that they will all sunset on 26 January. There will be a debate in this House next week on all the regulations, followed by votes.
(2 years, 11 months ago)
Commons ChamberTo support people who may have the challenges to which the hon. Gentleman referred, sick pay will begin on day one. We also have the hardship fund, which can help with particular cases.
The travel sector has been devastated by uncertainty and constantly changing rules. I welcome the Secretary of State’s saying that that these measures are temporary, but will he set out in detail the criteria on which he will decide whether they should be lifted and when?
I fully understand my right hon. Friend’s point about the impact on the travel sector; that should not be lost on anyone. We all understand why the action has been taken, but we must not forget that the sector is hugely important to the economy, and that it has been hit hard again and again. Next week’s update—the review point—will be important to provide more certainty. As I said to the hon. Member for Wallasey (Dame Angela Eagle), we cannot guarantee that we will have all the answers to our questions, but that information will certainly help to provide more certainty.
(2 years, 12 months ago)
Commons ChamberFirst, I think it is fair to say that our genomics surveillance has never been so strong. It was getting stronger even before the pandemic, but because of the pandemic, there has been a huge amount of investment, and it has paid off UK-wide. On the treatments, there is some concern about this new variant and Ronapreve, which is one of the key monoclonal antibodies that we use for treatment, but it is just concern at this point; there is no particular evidence. However, part of the reason for taking these measures is to buy the time we need—two to three weeks—to give our scientists time to assess the risk of this variant properly.
First, what assessment has the Secretary of State made of the early reports from South Africa that the variant may actually lead to less severe illness than the previous variants? Secondly, I welcome the fact that we will have both a debate and vote tomorrow on these regulations, but would it not be better if we had the debate and the vote before the restrictions come into force, rather than after?
I believe that right after my statement the Leader of the House will be making a statement about the debate and vote tomorrow.
On the severity, there are reports, as my hon. Friend has said, but it is early days and we are looking into them, talking with our South African friends and getting more details. It is worth pointing out the difference in age profile and demographics: in South Africa, people with covid are on average younger, and we are taking that into account as well.
(3 years, 1 month ago)
Commons ChamberI thank the hon. Lady for what she has said, but I think the Government have already set out clearly the provisions that they intend to expire or suspend, subject to the will of the House today, and explained why they have focused on those provisions. I can also inform the House that we recommend the suspension of the remaining unsuspended parts of schedule 28 and section 58.
I am sure the whole House will welcome this news—the latest steps that we are taking towards a more normal way of life—but the winter just around the comer is a cause for caution, with the twin threats of covid-19 and flu still uncertain. In line with our autumn and winter plan, we intend to retain the temporary provisions that remain essential to our ongoing pandemic work, including sections 2, 6, 14, 38, 45, 50 and 75, which cover vital aspects such as supporting the NHS to help it to retain emergency staff and enabling statutory sick pay to be provided for people who are self-isolating. We will review this legislation again in the spring.
Will my right hon. Friend explain in detail which of the measures that the Government seek to retain could not be implemented alternatively by means of the Civil Contingencies Act or the Public Health (Control of Disease) Act 1984?
My hon. Friend will know that there are numerous measures that the Government are planning to retain. To do proper justice to his question, I would have to go through them one by one and try to link them with every single Act, but I should be happy to meet him or write to him giving him the proper detail, because I think it was a very fair question.
(3 years, 2 months ago)
Commons ChamberThe hon. Lady is right to raise this important issue. Throughout the pandemic we have offered advice for those who are immunocompromised and given guidance through clinicians working with the NHS, and that is constantly updated as the nature of the covid threat is constantly changing. As I said a moment ago, we got clear advice that for certain people who are immunocompromised but can take the vaccine—I think it affects about 500,000 people—the antibody response from two doses was not enough and there should be a third dose as part of a primary course. We accepted that advice and acted on it immediately. We will continue to keep that under review and do whatever we can.
I welcome the Government’s rethink on vaccine passports and hope that it presages a move to trusting people more to make decisions for themselves. The Secretary of State will know about the evidence that people who returned from green list and amber list countries over the summer had a lower level of covid than those who stayed here. Does he accept that that makes a powerful case for getting rid of the day 2 PCR test for people returning from those countries?
My hon. Friend is right to raise that point. That is why we have kept our travel rules relating to covid constantly under review. He may have heard that I referred in my statement to a set of changes that we are looking to make, and my right hon. Friend the Transport Secretary will bring those changes to the House as soon as he possibly can.
(3 years, 4 months ago)
Commons ChamberI am afraid that the hon. Lady is just not being realistic. I have set out very clearly in my statement the issues around timing. No one is pretending that there is a perfect time to start lifting some of these restrictions. It therefore requires a balanced and measured approach, and that is exactly what we are doing.
Steroid inhalers, of the type used by millions of asthma sufferers worldwide, are known to be safe and cheap, and trials show that they are also very effective in reducing the severity of covid symptoms and the length of time they are suffered. Will my right hon. Friend take rapid steps to revise the guidance to ensure that this becomes an immediate part of GPs’ armoury in dealing with people who present with covid symptoms?
When my hon. Friend wants something done rapidly, I listen very carefully to him. I am pleased to tell him that the clinical guidelines have been published today that allow the central alerting system to recommend to clinicians that they prescribe inhaled steroids on a case-by-case basis for exactly the purpose that he set out. I hope that is quick enough for him.